Role of Endothelial Progenitor Cells in Restenosis and Progression of Coronary Atherosclerosis After Percutaneous Coronary Intervention. A Prospective Study

JACC: Cardiovascular Interventions

Volumn 3, Issue 1, 2010, Pages 78-86

  Pelliccia, Francesco ^a,c   Cianfrocca, Cinzia ^a,c   Rosano, Giuseppe ^b   Mercuro, Giuseppe ^c   Speciale, Giulio ^a   Pasceri, Vincenzo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

angiogenesis; endothelial progenitor cells; percutaneous coronary intervention; restenosis; stem cells

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD45 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CELL SUBPOPULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE CONTROL; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART FUNCTION; HUMAN; HUMAN CELL; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; STEM CELL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD; ANTIGENS, CD45; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINEAGE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PROSPECTIVE STUDIES; STEM CELLS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 74049138752     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.020     Document Type: Article

References (30)

1. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
2. Leor J., and Marber M. Endothelial progenitors. A new tower of Babel?. J Am Coll Cardiol 48 (2006) 1588-1590
3. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., and Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45 (2005) 1441-1448
4. George J., Herz I., Goldstein E., et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23 (2003) e57-e60
5. Kipshidze N., Dangas G., Tsapenko M., et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44 (2004) 733-739
6. Schober A., Hoffmann R., Oprée N., et al. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease. Am J Cardiol 96 (2005) 1116-1122
7. Inoue T., Sata M., Hikichi Y., et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115 (2007) 553-561
8. Lee L.C., Chen C.S., Choong P.F., Low A., Tan H.C., and Poh K.K. Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabetics. Int J Cardiol (2009 Jan 19) [E-pub ahead of print]
9. Banerjee S., Brilakis E., Zhang S., et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 189 (2006) 70-75
10. Güven H., Shepherd R.M., Bach R.G., Capoccia B.J., and Link D.C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48 (2006) 1579-1587
11. Glaser R., Selzer F., Faxon D.P., et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111 (2005) 143-149
12. Dens J.A., Desmet W.J., Coussement P., et al. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. Heart 89 (2003) 887-892
13. Sutherland D.R., Anderson L., Keeney M., Nayar R., and Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5 (1996) 213-226
14. Fadini G.P., de Kreutzenberg S.V., Coracina A., et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 27 (2006) 2247-2255
15. Salven P., Mustjoki S., Alitalo R., Alitalo K., and Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101 (2003) 168-172
16. Wang Y., Johnsen H.E., Mortensen S., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92 (2006) 768-774
17. Sieveking D.P., Buckle A., Celermajer D.S., and Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51 (2008) 660-668
18. Waters D., Lespérance J., Craven T.E., Hudon G., and Gillam L.D. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis: implications for clinical trials. Circulation 87 Suppl II (1993) 38-47
19. Reiber J.H., Serruys P.W., Kooijman C.J., et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71 (1985) 280-288
20. Dieker H.J., French J.K., Joziasse I.C., et al. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction. Am Heart J 153 (2007) 66.e1-66.e8
21. Popma J.J., Leon M.B., Moses J.W., et al., SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 110 (2004) 3773-3780
22. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation 111 (2005) 2981-2987
23. Kunz G.A., Liang G., Cuculi F., et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 152 (2006) 190-195
24. Werner N., Kosiol S., and Schiegl T. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
25. Berry C., L'Allier P.L., Grègoire J., et al. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 115 (2007) 1851-1857
26. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
27. Hibbert B., Chen Y.-X., and O'Brien E.R. c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol 287 (2004) H518-H524
28. Skowasch D., Jabs A., Andrié R., Dinkelbach S., Lüderitz B., and Bauriedel G. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc Res 60 (2003) 684-691
29. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
30. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024